Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
4.580
+0.140 (3.15%)
At close: Mar 27, 2026

Revenue by Segment

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Blood Management Products
995.11M876.78M1.04B1.10B976.86M
Blood Management Products Growth
13.50%-15.86%-5.10%12.40%17.86%
Medical Device Products
6.67B6.60B7.01B6.83B6.52B
Medical Device Products Growth
1.08%-5.81%2.59%4.75%8.85%
Eliminations
-94.07M-88.05M-45.80M-50.80M-109.00K
Orthopaedic Products
1.52B1.44B1.27B2.04B2.13B
Orthopaedic Products Growth
5.78%13.23%-37.63%-4.16%21.27%
Interventional Products
2.01B1.98B1.93B1.73B1.54B
Interventional Products Growth
1.30%2.54%11.87%11.78%12.49%
Pharma Packaging Products
2.29B2.28B2.02B2.11B2.04B
Pharma Packaging Products Growth
0.41%12.59%-3.88%3.19%20.46%
Total
13.39B13.09B13.23B13.75B13.21B
Total Growth
2.31%-1.08%-3.77%4.08%13.65%

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
People's Republic of China (PRC)
9.82B9.80B10.20B10.58B10.55B
People's Republic of China (PRC) Growth
0.19%-3.97%-3.57%0.28%16.08%
United States
1.45B1.40B1.30B1.27B1.15B
United States Growth
3.08%7.74%2.32%11.03%0.56%
Europe, The Middle East and Africa
983.23M850.89M709.69M563.22M501.92M
Europe, The Middle East and Africa Growth
15.55%19.90%26.01%12.21%-0.31%
Asia and Others
1.14B1.03B1.01B--
Asia and Others Growth
10.44%2.02%---
Other
---1.33B1.01B
Other Growth
---31.85%225.55%
Total
13.39B13.09B13.23B13.75B13.21B
Total Growth
2.31%-1.08%-3.77%4.08%13.65%
Source: S&P Global Market Intelligence.